Concurrent validity of Peabody motor developmental scales-2 and the Gesell developmental scales in children with cerebral palsy
10.3760/cma.j.issn.0254-1424.2009.07.007
- VernacularTitle:Peabody运动发育量表-2与Gesell发育量表在脑性瘫痪患儿中的平行效度研究
- Author:
Paoqiu WANG
;
Huijia ZHANG
;
Rong QIN
;
Yimei WANG
;
Hongtao ZHOU
- Publication Type:Journal Article
- Keywords:
Peabody developmental motor scale 2;
Gesell's developmental scales;
Concurrent validity;
Cerebral palsy
- From:
Chinese Journal of Physical Medicine and Rehabilitation
2009;31(7):452-455
- CountryChina
- Language:Chinese
-
Abstract:
Objective To examine the concurrent validity of Peabody'S developmental motor scale number 2(PDMS-2)and Gesell's developmental scales with 1 2 to 30 month-old children with cerebral palsy (CP)and to assess the value of PDMS-2 in measuring motor function in children with CP.Methods Eighty-four children with CP aged 12 to 30 months were assessed with both PDMS-2 and Gesell's developmental scales.The correlation between PDMS-2 gross motor quotients and Gesell gross motor developmental quotients,and be-tween PDMS-2 fine motor quotients and Gesell fine motor developmental quotients were compared using Spearman rank correlation coefficients. Results The correlation coefficient between PDMS-2 gross motor quo-tient and the Gesell gross motor developmental quotient was 0.89.Between PDMS-2 fine motor quotient and Gesell's fine motor developmental quotient it was 0.87.The concurrent validities were 0.28 and 0.42 respec-tively. Conclusion PDMS-2 gross motor quotient and Gesell's gross motor developmental quotient are highly correlated,as are PDM S-2 fine motor quotient and Gesell's fine motor developmental quotient.The concurrent validities were between classifications using the PDMS-2 gross motor quotient and Gesell's gross motor develop- mental quotient were weakly correlated,but there was moderate correlation between PDM S-2 fine motor quotientsand Gesell fine gross developmental quotients.There may be limitations in assessing motor function children aged12 to 30 months with cerebral palsy using PDMS-2.
